Our Work

News
April 2023

dQ&A® and CeQur Publication Featured in Clinical Diabetes

dQ&A team member, Erik Shoger, recently co-authored Patient Perceptions of Satisfaction and Quality of Life Regarding Use of a Novel Insulin Delivery Device in Clinical Diabetes.

Key details from this publication:

We surveyed individuals with type 1 or type 2 diabetes to explore their attitudes and satisfaction after using the CeQur Simplicity insulin patch (SIP) for 2 months. Transition to the SIP yielded significant increases in respondents’ overall treatment satisfaction, less diabetes burden, and improvements in psychological well-being compared with respondents’ prior insulin delivery method.

Read the full piece in the Clinical Diabetes journal!

About dQ&A – The Diabetes Research Company

dQ&A is a social enterprise committed to making life better for people with diabetes. We harness patient voices to drive better business results and better health outcomes. For over 14 years, we have been comprehensively tracking the diabetes experience in the United States, Canada, and Europe. We are trusted by diabetes industry leaders for our independence, commitment, and expertise. Our team has decades of experience in quantitative and qualitative research with a deep knowledge of diabetes. We’re efficient and effective; our insights are actionable and accessible. To learn more, send us an email at info@d-qa.com. For research highlights, visit us at d-qa.com and follow us on LinkedIn (dQ&A – The Diabetes Research Company)

Share this post
News

Suggested Articles

Where can we take you next?